Cargando…

Validation of disease states in schizophrenia: comparison of cluster analysis between US and European populations

BACKGROUND: There is controversy as to whether use of statistical clustering methods to identify common disease patterns in schizophrenia identifies patterns generalizable across countries. OBJECTIVE: The goal of this study was to compare disease states identified in a published study (Mohr/Lenert,...

Descripción completa

Detalles Bibliográficos
Autores principales: Thokagevistk, Katia, Millier, Aurélie, Lenert, Leslie, Sadikhov, Shamil, Moreno, Santiago, Toumi, Mondher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Co-Action Publishing 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4916257/
https://www.ncbi.nlm.nih.gov/pubmed/27386054
http://dx.doi.org/10.3402/jmahp.v4.30725
_version_ 1782438797987807232
author Thokagevistk, Katia
Millier, Aurélie
Lenert, Leslie
Sadikhov, Shamil
Moreno, Santiago
Toumi, Mondher
author_facet Thokagevistk, Katia
Millier, Aurélie
Lenert, Leslie
Sadikhov, Shamil
Moreno, Santiago
Toumi, Mondher
author_sort Thokagevistk, Katia
collection PubMed
description BACKGROUND: There is controversy as to whether use of statistical clustering methods to identify common disease patterns in schizophrenia identifies patterns generalizable across countries. OBJECTIVE: The goal of this study was to compare disease states identified in a published study (Mohr/Lenert, 2004) considering US patients to disease states in a European cohort (EuroSC) considering English, French, and German patients. METHODS: Using methods paralleling those in Mohr/Lenert, we conducted a principal component analysis (PCA) on Positive and Negative Syndrome Scale items in the EuroSC data set (n=1,208), followed by k-means cluster analyses and a search for an optimal k. The optimal model structure was compared to Mohr/Lenert by assigning discrete severity levels to each cluster in each factor based on the cluster center. A harmonized model was created and patients were assigned to health states using both approaches; agreement rates in state assignment were then calculated. RESULTS: Five factors accounting for 56% of total variance were obtained from PCA. These factors corresponded to positive symptoms (Factor 1), negative symptoms (Factor 2), cognitive impairment (Factor 3), hostility/aggression (Factor 4), and mood disorder (Factor 5) (as in Mohr/Lenert). The optimal number of cluster states was six. The kappa statistic (95% confidence interval) for agreement in state assignment was 0.686 (0.670–0.703). CONCLUSION: The patterns of schizophrenia effects identified using clustering in two different data sets were reasonably similar. Results suggest the Mohr/Lenert health state model is potentially generalizable to other populations.
format Online
Article
Text
id pubmed-4916257
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Co-Action Publishing
record_format MEDLINE/PubMed
spelling pubmed-49162572016-07-06 Validation of disease states in schizophrenia: comparison of cluster analysis between US and European populations Thokagevistk, Katia Millier, Aurélie Lenert, Leslie Sadikhov, Shamil Moreno, Santiago Toumi, Mondher J Mark Access Health Policy Original Research Article BACKGROUND: There is controversy as to whether use of statistical clustering methods to identify common disease patterns in schizophrenia identifies patterns generalizable across countries. OBJECTIVE: The goal of this study was to compare disease states identified in a published study (Mohr/Lenert, 2004) considering US patients to disease states in a European cohort (EuroSC) considering English, French, and German patients. METHODS: Using methods paralleling those in Mohr/Lenert, we conducted a principal component analysis (PCA) on Positive and Negative Syndrome Scale items in the EuroSC data set (n=1,208), followed by k-means cluster analyses and a search for an optimal k. The optimal model structure was compared to Mohr/Lenert by assigning discrete severity levels to each cluster in each factor based on the cluster center. A harmonized model was created and patients were assigned to health states using both approaches; agreement rates in state assignment were then calculated. RESULTS: Five factors accounting for 56% of total variance were obtained from PCA. These factors corresponded to positive symptoms (Factor 1), negative symptoms (Factor 2), cognitive impairment (Factor 3), hostility/aggression (Factor 4), and mood disorder (Factor 5) (as in Mohr/Lenert). The optimal number of cluster states was six. The kappa statistic (95% confidence interval) for agreement in state assignment was 0.686 (0.670–0.703). CONCLUSION: The patterns of schizophrenia effects identified using clustering in two different data sets were reasonably similar. Results suggest the Mohr/Lenert health state model is potentially generalizable to other populations. Co-Action Publishing 2016-06-20 /pmc/articles/PMC4916257/ /pubmed/27386054 http://dx.doi.org/10.3402/jmahp.v4.30725 Text en © 2016 Katia Thokagevistk et al. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 International License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for any purpose, even commercially, provided the original work is properly cited and states its license.
spellingShingle Original Research Article
Thokagevistk, Katia
Millier, Aurélie
Lenert, Leslie
Sadikhov, Shamil
Moreno, Santiago
Toumi, Mondher
Validation of disease states in schizophrenia: comparison of cluster analysis between US and European populations
title Validation of disease states in schizophrenia: comparison of cluster analysis between US and European populations
title_full Validation of disease states in schizophrenia: comparison of cluster analysis between US and European populations
title_fullStr Validation of disease states in schizophrenia: comparison of cluster analysis between US and European populations
title_full_unstemmed Validation of disease states in schizophrenia: comparison of cluster analysis between US and European populations
title_short Validation of disease states in schizophrenia: comparison of cluster analysis between US and European populations
title_sort validation of disease states in schizophrenia: comparison of cluster analysis between us and european populations
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4916257/
https://www.ncbi.nlm.nih.gov/pubmed/27386054
http://dx.doi.org/10.3402/jmahp.v4.30725
work_keys_str_mv AT thokagevistkkatia validationofdiseasestatesinschizophreniacomparisonofclusteranalysisbetweenusandeuropeanpopulations
AT millieraurelie validationofdiseasestatesinschizophreniacomparisonofclusteranalysisbetweenusandeuropeanpopulations
AT lenertleslie validationofdiseasestatesinschizophreniacomparisonofclusteranalysisbetweenusandeuropeanpopulations
AT sadikhovshamil validationofdiseasestatesinschizophreniacomparisonofclusteranalysisbetweenusandeuropeanpopulations
AT morenosantiago validationofdiseasestatesinschizophreniacomparisonofclusteranalysisbetweenusandeuropeanpopulations
AT toumimondher validationofdiseasestatesinschizophreniacomparisonofclusteranalysisbetweenusandeuropeanpopulations